Prevention and Control of Coronavirus Disease 2019: Where Do We Go From Here?
AuthorNeuzil, Kathleen M.
JournalClinical infectious diseases
PublisherInfectious Diseases Society of America
MetadataShow full item record
AbstractRespiratory viruses have plagued humanity for millennia. The latest respiratory virus to emerge—severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)—has caused the pandemic of our lifetimes. The social, economic, and health consequences have been staggering, and the end is not yet in sight. Historic vaccine development efforts with rapid rollout of highly effective vaccines in the United States and elsewhere have prevented millions of cases and saved hundreds of thousands of lives. Yet, more than a year after emergency use authorization of coronavirus disease 2019 (COVID-19) vaccines, almost half of the global population remains unvaccinated, and <10% of people in low-income countries have received a single dose of vaccine. These large unvaccinated populations, and vaccinated populations with poor vaccine responses, remain at high risk for serious outcomes and death due to COVID-19
Identifier to cite or link to this itemhttp://hdl.handle.net/10713/19731